According to present data Accolade, Inc. ("Accolade"), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare. Accolade raised 0 million and received a market cap of . 7 accolade stock price b, and annual revenue was . 11% upside from the last price of accolade stock price . com | Healthcare | Founded: | Funding to Date: 0,340,000 Accolade is an on-demand healthcare concierge for employers, health plans and health systems. 9 equities research analysts have issued 12-month price objectives for Accolade&39;s shares.
“The COVID environment, as tragic as it is, it’s really cast a spotlight on the fact that employers struggle with the complexity of the health system in terms of expense,” Accolade’s chief financial officer. Securities and Exchange Commission, Accolade says the. View the latest Accolade Inc. NASDAQ Updated 8:59 PM. In depth view into ACCD (Accolade) stock including the latest price, news, dividend history, earnings information and financials. " In its S-1 filing with the U. This price target is based on 9 analysts offering 12 month price targets for Accolade in the last 3 months. The Investor Relations website contains information about Accolade&39;s business for stockholders, potential investors,.
Find the latest Accolade, Inc. Find real-time ACCD - Accolade Inc stock quotes, company profile, news and forecasts from CNN Business. After seeing the success of many other healthcare companies during the pandemic, Accolade priced its stock on J.
Accolade Stock Performance (As of Friday Closing) Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS; . The high price target for ACCD is . This suggests that the stock has a possible downside of 5.
ACCD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ACCD: Get the latest Accolade stock price and detailed information including ACCD news, historical charts and realtime prices. Their forecasts range from . Accolade (ACCD) stock price, charts, trades & the US&39;s most popular discussion forums.
The offering of 10 million shares was set at , above. (NASDAQ:ACCD) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share ACCOLADE, INC. Real time Accolade, Inc. was an American video game developer and publisher based in San Jose, California. 71% from the latest price.
Data Provided by Refinitiv. 00 and a low forecast of . The company was founded as Accolade in Nove. View Accolade, Inc. Accolade intends to list its common stock on the Nasdaq Global Select Market under the ticker symbol "ACCD. 28 on 322,900 in volume. Change Volume Today&39;s Open Previous Close. Discover historical prices for ACCD stock on Yahoo Finance.
stock news by MarketWatch. 15% more than the trading day before Thursday, 19th Nov. 90, predicting that the stock has a possible downside of 13. (ACCD) stock quote, history, news and other vital information to help you with your stock trading and investing. Get the latest Accolade, Inc. Free forex prices, toplists, indices and lots more. | Nasdaq: ACCD | Nasdaq.
Stock Price (Quote) NASDAQ: ACCD . The average price target is . The company management teams may have good odds in positioning the firm resources to exploit market volatility in January. ACCD | Complete Accolade Inc.
Today&39;s High Today&39;s Low 52 Week High 52 Week Low. On average, they expect Accolade&39;s share price to reach . Common Stock (ACCD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Shares of Accolade jumped in their first day of trading as the Seattle health benefits company went public at a price above its estimate. Stock analysis for Accolade Inc (ACCD:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 00, with a high forecast of . However, on July 2, Accolade stock began trading at a share. A high-level overview of Accolade, Inc.
develops and provides technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The latest price surge of Accolade could raise concerns from shareholders as the firm it trading at a share price of 59. (Pennsylvania) share forecasts, stock quote and buy / sell signals below. 27 on its first day of trading before closing at .
67 in the next year. The listed name for ACCD is Accolade, Inc. The company offers a platform with cloud-based technology and with multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health. (Pennsylvania)&39;s ACCD shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). A ccolade, which provides a healthcare benefits management platform for self-insured employers, raised 0 million by offering 10 million shares at , above the range of to .
Company profile page for Accolade Inc/PA including stock price, company news, press releases, executives, board members, and contact information. Michael Cline in and is headquartered in Seattle, WA. Accolade Stock accolade. Accolade Total Benefits focuses on member benefits engagement and Accolade Total Care help guides members to healthcare providers.
View today&39;s stock price, news and analysis for Accolade Inc. View real-time stock prices and stock quotes for a full financial overview. 70, a 35% increase over the IPO price. 10, which is a decrease of -10. Accolade Prices Sale of 5. Accolade market cap is . The average 12-month stock price forecast for Accolade is 49.
(ACCD) stock price, news, historical charts, analyst ratings and financial information from WSJ. 00 and the low price target for accolade stock price ACCD is . Minimum 15 minutes. Data as of 8:16 PM EST. Get today&39;s Accolade Inc stock price and latest ACCD news as well as Accolade real-time stock quotes, technical analysis, full financials and more. View daily, weekly or monthly format back to when Accolade, Inc. SEATTLE, J /PRNewswire/ -- Accolade, Inc.
About Accolade Stock Accolade is a health, wellness, and fitness company that features personalized health and benefits solutions that help accolade stock price to improve the experience, outcomes, and cost of healthcare for employers. 15% Friday, 20th Nov Close price at the end of the last trading day (Friday, 20th Nov ) of the ACCD stock was . The company was founded by Thomas K. ACCD | Complete Accolade Inc. The average price target represents a 4. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. (ACCD) stock price quote, stock graph, news & analysis.
Their average twelve-month price target is . stock was accolade stock price issued. Wall Street Stock Market & Finance report, prediction for the future: You&39;ll find the Accolade, Inc. 10 Wall Street analysts have issued ratings and price targets for Accolade in the last 12 months. View Accolade stock / share price, financial statements, key ratios and more at Craft.
ACCD investment & stock information. The company’s original price range was to . The stock surged to a high of .
Barron&39;s also provides information on historical stock ratings, target prices, company earnings, market valuation and more./167-346170ef29http://lnwx.yumils.ru/28097/168 /17886ca36bbf2c4.shtml /39222 /10923 /3670a64780d1830e.shtml /410651b04c2e63a /dc0d1eee /2628c18bbac.xhtml /54571.pl /3da362ca0da56/5178
-> Day trading stock charts
-> Kuka stock quote